<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29061165</article-id>
<article-id pub-id-type="pmc">5654094</article-id>
<article-id pub-id-type="publisher-id">477</article-id>
<article-id pub-id-type="doi">10.1186/s12881-017-0477-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sustained endocrine profiles of a girl with WAGR syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Takada</surname>
<given-names>Yui</given-names>
</name>
<address>
<email>yuiyui113jp@yahoo.co.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5747-8692</contrib-id>
<name>
<surname>Sakai</surname>
<given-names>Yasunari</given-names>
</name>
<address>
<phone>+81-92-642-5421</phone>
<email>ysakai22q13@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsushita</surname>
<given-names>Yuki</given-names>
</name>
<address>
<email>matuyuki@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohkubo</surname>
<given-names>Kazuhiro</given-names>
</name>
<address>
<email>kohkubo@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koga</surname>
<given-names>Yuhki</given-names>
</name>
<address>
<email>yuuki-k@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akamine</surname>
<given-names>Satoshi</given-names>
</name>
<address>
<email>akamine@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torio</surname>
<given-names>Michiko</given-names>
</name>
<address>
<email>torio-m@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishizaki</surname>
<given-names>Yoshito</given-names>
</name>
<address>
<email>ishizaki@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanefuji</surname>
<given-names>Masafumi</given-names>
</name>
<address>
<email>sanefuji39@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torisu</surname>
<given-names>Hiroyuki</given-names>
</name>
<address>
<email>htorys@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>Chad A.</given-names>
</name>
<address>
<email>cashaw@bcm.edu</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kagami</surname>
<given-names>Masayo</given-names>
</name>
<address>
<email>kagami-ms@ncchd.go.jp</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hara</surname>
<given-names>Toshiro</given-names>
</name>
<address>
<email>harat@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohga</surname>
<given-names>Shouichi</given-names>
</name>
<address>
<email>ohgas@pediatr.med.kyushu-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2242 4849</institution-id><institution-id institution-id-type="GRID">grid.177174.3</institution-id><institution>Department of Pediatrics, Graduate School of Medical Sciences, </institution><institution>Kyushu University, </institution></institution-wrap>Fukuoka, 812-8582 Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9611 5902</institution-id><institution-id institution-id-type="GRID">grid.418046.f</institution-id><institution>Section of Pediatrics, Department of Medicine, Division of Oral &amp; Medical Management, </institution><institution>Fukuoka Dental College, </institution></institution-wrap>Fukuoka, 814-0193 Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution>Department of Molecular and Human Genetics, </institution><institution>Baylor College of Medicine, </institution></institution-wrap>Houston, 77030 USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0377 2305</institution-id><institution-id institution-id-type="GRID">grid.63906.3a</institution-id><institution>Department of Molecular Endocrinology, </institution><institution>National Research Institute for Child Health and Development, </institution></institution-wrap>Tokyo, 157-8535 Japan </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1764 8161</institution-id><institution-id institution-id-type="GRID">grid.410810.c</institution-id><institution>Present address: Fukuoka Children’s Hospital, </institution></institution-wrap>Fukuoka, 813-0017 Japan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.415613.4</institution-id><institution>Present address: Department of Pediatrics, National Hospital Organization Kyushu Medical Center, </institution></institution-wrap>Fukuoka, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>18</volume>
<elocation-id>117</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Wilms tumor, aniridia, genitourinary anomalies and mental retardation (WAGR) syndrome is a rare genetic disorder caused by heterozygous deletions of <italic>WT1</italic> and <italic>PAX6</italic> at chromosome 11p13<italic>.</italic> Deletion of <italic>BDNF</italic> is known eto be associated with hyperphagia and obesity in both humans and animal models; however, neuroendocrine and epigenetic profiles of individuals with WAGR syndrome remain to be determined.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">We report a 5-year-old girl with the typical phenotype of WAGR syndrome. She showed profound delays in physical growth, motor and cognitive development without signs of obesity. Array comparative genome hybridization (CGH) revealed that she carried a 14.4 Mb deletion at 11p14.3p12, encompassing the <italic>WT1</italic>, <italic>PAX6</italic> and <italic>BDNF</italic> genes. She experienced recurrent hypoglycemic episodes at 5 years of age. Insulin tolerance and hormonal loading tests showed normal hypothalamic responses to the hypoglycemic condition and other stimulations. Methylation analysis for freshly prepared DNA from peripheral lymphocytes using the pyro-sequencing-based system showed normal patterns of methylation at known imprinting control regions.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">Children with WAGR syndrome may manifest profound delay in postnatal growth through unknown mechanisms. Epigenetic factors and growth-associated genes in WAGR syndrome remain to be characterized.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12881-017-0477-5) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Wilms tumor, Aniridia, Genitourinary anomalies and mental retardation (WAGR) syndrome</kwd>
<kwd>Epigenetics</kwd>
<kwd>Neuroendocrine function</kwd>
<kwd>Methylation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Kakenhi</institution>
</funding-source>
<award-id>15K0962</award-id>
<principal-award-recipient>
<name>
<surname>Sakai</surname>
<given-names>Yasunari</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par9">Wilms tumor, aniridia, genitourinary anomalies and mental retardation (WAGR) syndrome is a rare genetic disorder caused by the chromosomal defect at 11p13.3 [<xref ref-type="bibr" rid="CR1">1</xref>]. Genetically, segmental deletions encompassing the <italic>WT1</italic> and <italic>PAX6</italic> genes are known to cause the syndromic phenotype, while an accompanying phenotype of obesity is linked to the extensive deletion involving the <italic>brain-derived neurotrophic factor</italic> (<italic>BDNF</italic>) locus [<xref ref-type="bibr" rid="CR2">2</xref>]. Thus, patients with the WAGR and obesity (O) phenotypes are designated as having WAGRO syndrome [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
<p id="Par10">Imprinting-associated disorders commonly present with abnormal physical growth and autism. Prader-Willi syndrome is an example of such diseases that are phenotypically characterized by muscular hypotonia in infancy, short stature and hyperphagic behavior with cognitive impairment later in childhood [<xref ref-type="bibr" rid="CR3">3</xref>]. Although autistic and hyperphagic behaviors are known to overlap between WAGRO and Prader-Willi syndromes, no information is currently available for epigenetic impacts of BDNF insufficiency on gene expression in the developing brain of humans and animals. This study was thus directed to test whether WAGRO syndrome might have deregulated conditions in neuroendocrine or methylation profiles.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par11">A 1-year and 10-month-old girl was referred to our department for assessment of growth delay and absence of speech. She was born at the 41st week of gestational age with birth weight of 2950 g. Congenital aniridia, cataracts and macular hypoplasia were noticed at birth. Genitourinary apparatus was normal in appearance.</p>
<p id="Par12">When she was first referred to our department at 1 year and 10 months of age, her height (74.4 cm, −2.8SD) and weight (8.5 kg, −3.3SD) were evaluated to be small for age. At this age, her motor skills and cognitive development were considered as low as 10 months of age. She developed bilateral renal tumors at 2 years and 1 month of age, for which surgical resection was conducted. Pathological examination confirmed the diagnosis of Wilms tumor. The renal tumors responded favorably to standard regimens of chemotherapy. She was well nourished without recurrence of tumors for over 4 years after the chemotherapy. Thus, the clinical features of this case fit to the typical phenotypes of WAGR syndrome, as previously reported [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par13">The G-band test revealed the karyotype of 46,XX,del(11)(p11.2p14) (Fig <xref ref-type="fig" rid="Fig1">1a</xref>). An array-comparative genome hybridization analysis (Clinical Microarray ver. 8.1 at Baylor MGL), and found the 14.5-Mb deletion at 11p14.3p12 (Fig <xref ref-type="fig" rid="Fig1">1a</xref>). The minimal segment of deletion were defined as arr[GRCh37] 11p14.3p12(24,792,569_39,222,929)×1. According to the GRCh37/hg19 assembly, the deleted region was located at the chromosomal band, 11p14.3p12. The deleted interval involved 50 genes in the adjacent loci, including <italic>PAX6</italic> (chr11:31,806,340–31,839,509) and <italic>WT1</italic> (chr11:32,409,322–32,457,081). The heterozygous deletions of <italic>WT1</italic> and <italic>BDNF</italic> were validated with FISH and qPCR analyses (Fig. <xref ref-type="fig" rid="Fig1">1b, c</xref>; see Additional file <xref ref-type="media" rid="MOESM1">1</xref>). We further excluded that this patient had a variant coding sequence of <italic>BDNF</italic> at the non-deleted allele (data not shown). Together, these data indicate that the heterozygous deletion of <italic>BDNF</italic>, but not a hypomorphic mutation, such as Val66Met variant [<xref ref-type="bibr" rid="CR5">5</xref>], caused the developmental delay in this patient. Because we were not allowed to analyze the parental chromosomes, it remained to be determined whether the deletion occurred de novo or as the consequence of chromosomal defects with lower penetrance, such as balanced translocations.<fig id="Fig1"><label>Fig. 1</label><caption><p>Genetic analyses of the present cases. <bold>a</bold> Array-CGH data for the present case. The left-top panel depicts the abnormal G-band pattern (arrow) of chromosome 11 in the peripheral leukocytes. On the right top, the log<sub>2</sub> values of relative copy numbers are plotted against the base position (x10E6) at chromosome 11. Color codes represent gain (green) or loss (red) of the probed regions. The horizontal dashed lines indicate the thresholds of duplication (0.5) and heterozygous deletion (−1.0). The lower-panel shows a magnified view of the deleted region. G-band locus (thick, black and gray lines) and protein-coding genes (blue boxes) are mapped on the coordinates available at the UCSC genome browser (GRCh37/hg19). Chromosomal locations of the three WAGR syndrome-associated genes (<italic>BDNF</italic>, <italic>PAX6</italic> and <italic>WT1</italic>) are denoted under the diagram. <bold>b</bold> The FISH image. The green (arrowheads) and red (arrows) signals show <italic>CCND1</italic> (control) and <italic>WT1</italic> loci, respectively. Note that one copy of the <italic>WT1</italic> (arrow) is missing while the two copies of <italic>CCND1</italic> signals (arrowheads) are unaffected. <bold>c</bold> Quantitative PCR data for this case and a healthy control. <italic>PRMT3</italic> (chr11:20,409,076–20,530,879) serves as an internal control. Bar plots show the relative copy numbers of <italic>WT1, PAX6</italic> and <italic>BDNF</italic> (mean ± SD, <italic>n</italic> = 4) to that of <italic>PRMT3</italic> for each individual</p></caption><graphic id="MO1" xlink:href="12881_2017_477_Fig1_HTML"></graphic></fig>
</p>
<p id="Par14">At 5 years of age, she reached 91.3 cm (−3.5 SD) of height and 12.45 kg (−2.2 SD) of body weight. She had recurrent episodes of ketogenic hypoglycemia on starvation. To assess whether she may have neuro-endocrine dysfunction, we conducted a series of hormonal loading tests. Insulin tolerance test (0.1 U/kg) revealed that her blood glucose rapidly declined to 35 mg/dl after infusion, while growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol were all normally increased in response to the hypoglycemic condition at 15–30 min (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2A). Combined infusion of 500 μg/kg L-arginine, 1.5 μg/kg CRH and 10 μg/kg TRH induced normal patterns of release in corresponding hormones (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2B). Oral glucose tolerance test with 1.75 g/kg of glucose resulted in normally fluctuated blood glucose and insulin levels, while lactate and pyruvate did not show abnormal patterns of accumulation (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2C). These data reassured that she had no obvious predisposing causes for hypoglycemia. She was likely intolerant of starved conditions owing to immature energy homeostasis as frequently observed in preschool children, but not as a consequence of WAGR-relevant phenotype.</p>
<p id="Par15">This case had typical growth and neurodevelopmental profiles as WAGR syndrome with large chromosomal deletions (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>]. We therefore considered it valuable to characterize her epigenetic profiles, which might disclose one of molecular mechanisms for delays in postnatal growth and development in WAGR syndrome. Recent studies indicated that chromosomal defects in the WAGR-critical region encompassed the <italic>LGR4</italic> gene [<xref ref-type="bibr" rid="CR6">6</xref>]. The heterozygous deletion of <italic>LGR4</italic> was reported to cause the secondary effects on the epigenetic status through disturbing the expression of chromatin modifier proteins. Towards this end, we investigated whether children with WAGR syndrome might bear aberrant methylation profiles on previously known imprinting regions. However, this case had normal methylation patterns at known loci for imprinting-associated disorders when using lymphocytes (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1) [<xref ref-type="bibr" rid="CR7">7</xref>]. CARE guidelines were followed in reporting this case.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Phenotypic spectrum of WAGR syndrome with 10 Mb or larger deletions</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No</th><th>Case ID</th><th>Age</th><th>Sex</th><th>Reference (Author, Year)</th><th>Cytoband</th><th>Size (Mb)</th><th>Genome<break></break>Assembly</th><th>Start point</th><th>End point</th><th>Height</th><th>Body<break></break>weight</th><th>Neurological Signs<sup><italic>a</italic></sup>
</th></tr></thead><tbody><tr><td>1</td><td>F24a</td><td>16</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p12p15.1</td><td>23.0</td><td>GRCh 35 (hg17)</td><td>20,040,419</td><td>43,071,919</td><td>NA</td><td>NA</td><td>ID, OCD</td></tr><tr><td>2</td><td>F8a</td><td>11</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>19.1</td><td>GRCh 35 (hg17)</td><td>25,086,501</td><td>44,212,278</td><td>NA</td><td>NA</td><td>ID, OCD, ASD</td></tr><tr><td>3</td><td>NIH10</td><td>6</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p11.2p14.1</td><td>18.2</td><td>GRCh 35 (hg17)</td><td>27,656,700</td><td>45,858,752</td><td>NA</td><td>NA</td><td>DD</td></tr><tr><td>4</td><td>F17a</td><td>36</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>15.6</td><td>GRCh 35 (hg17)</td><td>25,086,501</td><td>40,651,423</td><td>NA</td><td>NA</td><td>ID, ASD, ADHD,<break></break>OCD, Anxiety</td></tr><tr><td>5</td><td>NIH3</td><td>4</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>15.3</td><td>GRCh 35 (hg17)</td><td>24,202,909</td><td>39,529,029</td><td>NA</td><td>NA</td><td>DD</td></tr><tr><td>6</td><td>F10a</td><td>7</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p11.2p13</td><td>14.9</td><td>GRCh 35 (hg17)</td><td>31,284,414</td><td>46,194,871</td><td>NA</td><td>NA</td><td>ID, DD, OCD,<break></break>Anxiety</td></tr><tr><td>7</td><td>F20a</td><td>15</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>14.6</td><td>GRCh 35 (hg17)</td><td>25,844,571</td><td>40,482,022</td><td>NA</td><td>NA</td><td>ID, DD, ASD,<break></break>ADHD, OCD,<break></break>Anxiety</td></tr><tr><td>8</td><td>YS 013</td><td>5</td><td>F</td><td>[This study]</td><td>11p14.3p12</td><td>14.4</td><td>GRCh37 (hg19)</td><td>24,792,569</td><td>39,222,929</td><td>91.3 cm<break></break>(−3.5 SD)</td><td>12.45 kg<break></break>(−2.2 SD)</td><td>DD, ASD,<break></break>Hyperphagia</td></tr><tr><td>9</td><td>NIH9</td><td>7</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p13p15.1</td><td>14.4</td><td>GRCh 35 (hg17</td><td>20,759,560</td><td>35,124,532</td><td>NA</td><td>NA</td><td>ID, ASD</td></tr><tr><td>10</td><td>F7a</td><td>13</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>14.3</td><td>GRCh 35 (hg17</td><td>24,542,321</td><td>38,824,714</td><td>NA</td><td>NA</td><td>ASD, DD, ADHD</td></tr><tr><td>11</td><td>NIH6</td><td>17</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.2</td><td>14.2</td><td>GRCh 35 (hg17</td><td>26,005,134</td><td>40,174,102</td><td>NA</td><td>NA</td><td>ID, ASD, ADHD,<break></break>Anxiety</td></tr><tr><td>12</td><td>NIH2</td><td>19</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p13p15.1</td><td>13.5</td><td>GRCh 35 (hg17</td><td>20,135,621</td><td>33,614,001</td><td>NA</td><td>NA</td><td>ID, ASD</td></tr><tr><td>13</td><td>F3a</td><td>26</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p12p13</td><td>12.9</td><td>GRCh 35 (hg17</td><td>31,284,414</td><td>44,212,278</td><td>NA</td><td>NA</td><td>ID, DD, Seizure,<break></break>Depression</td></tr><tr><td>14</td><td>F21a</td><td>12</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.3</td><td>12.5</td><td>GRCh 35 (hg17)</td><td>25,336,593</td><td>37,873,278</td><td>NA</td><td>NA</td><td>ADHD, OCD,<break></break>Anxiety</td></tr><tr><td>15</td><td>F14a</td><td>12</td><td>F</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.1</td><td>12.2</td><td>GRCh 35 (hg17)</td><td>28,001,853</td><td>40,239,548</td><td>NA</td><td>NA</td><td>ID, ASD, OCD,<break></break>Anxiety, ADHD</td></tr><tr><td>16</td><td>F1a</td><td>11</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p13p14.3</td><td>11.4</td><td>GRCh 35 (hg17)</td><td>24,848,855</td><td>36,266,146</td><td>NA</td><td>NA</td><td>ID, ASD, Anxiety,<break></break>OCD</td></tr><tr><td>17</td><td>NIH11</td><td>4</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.2</td><td>10.7</td><td>GRCh 35 (hg17)</td><td>26,690,778</td><td>37,341,623</td><td>NA</td><td>NA</td><td>ID, ASD</td></tr><tr><td>18</td><td>F23a</td><td>16</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.1</td><td>10.6</td><td>GRCh 35 (hg17)</td><td>27,675,634</td><td>38,235,380</td><td>NA</td><td>NA</td><td>ID, ASD, DD, OCD</td></tr><tr><td>19</td><td>Patient 2</td><td>2</td><td>F</td><td>Yamamoto T,<break></break>2013 [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td>11p13p12</td><td>10.5</td><td>GRCh 35 (hg17)</td><td>32,990,627</td><td>43,492,580</td><td>75.6 cm<break></break>(−3.5SD)</td><td>11.9 kg<break></break>(+0.8SD)</td><td>DD</td></tr><tr><td>20</td><td>NIH1</td><td>26</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.1</td><td>10.2</td><td>GRCh 35 (hg17)</td><td>27,692,635</td><td>37,916,281</td><td>NA</td><td>NA</td><td>ID, ASD</td></tr><tr><td>21</td><td>F19a</td><td>5</td><td>M</td><td>Xu S, 2008 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>11p14p12.2</td><td>10.1</td><td>GRCh 35 (hg17)</td><td>26,699,475</td><td>36,757,882</td><td>NA</td><td>NA</td><td>ID, DD, ASD</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>
<italic>Abbreviations</italic>: <italic>ID</italic> intellectual disability, <italic>OCD</italic> obsessive compulsive disorder, <italic>ASD</italic>, autism spectrum disorder, <italic>DD</italic>, developmental delay, <italic>ADHD</italic>, attention deficit hyperactive disorder</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusions</title>
<p id="Par16">We described a girl with typical phenotypes of WAGR syndrome. By defining the deleted interval in the short arm of chromosome 11, we confirmed that she had heterozygous deletions of <italic>WT1</italic>, <italic>PAX6</italic> and <italic>BDNF1</italic>. The <italic>BDNF</italic> gene encodes brain-derived neurotrophic factor, one of the most potent activators of neurogenesis and synaptogenesis in the central nervous system [<xref ref-type="bibr" rid="CR8">8</xref>]. Precise mechanisms for developing the obesity phenotype with <italic>BDNF</italic> deletion remain to be elusive; however, hypothalamic dysfunctions due to hypomorphic mutation of <italic>BDNF</italic> have been proposed in both humans and animal models [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Although our case did not show hyperphagic behaviors during this study period, her metabolic status may be deranged to drive this phenotype in later stages.</p>
<p id="Par17">BDNF and its cognate receptor, tyrosine receptor kinase B (TrkB), coordinate glucose metabolism and energy homeostasis in the hypothalamus [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Because we were unable to detect hyper- or hypo-functioning responses to hormonal loading tests in this case, she was likely to experience hypoglycemic episodes on starvation without specific causes in the neuro-endocrine system. However, one could still argue that such hypothalamic dysfunctions might be evident only when she develops obesity. Thus, serial observation of physical growth and its correlation with hyperphagic and autistic behaviors in childhood through adolescence will be necessary to clarify the neural bases for obese phenotype of WAGR syndrome.</p>
<p id="Par18">We further verified that she had unaltered methylation profiles at the CpG sites of previously known imprinting genes. Although it still remains unknown why the segmental deletion at 11p15 lead to short stature in WAGR syndrome in early childhood, these data provide a clue for directing future epigenetic study on WAGR syndrome. Consecutive evidence in future studies will warrant these data and provide insight into genotype-phenotype correlations for children with WAGR syndrome.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec4">
<title>Additional file</title>
<p id="Par24">
<media id="MOESM1" position="anchor" xlink:href="12881_2017_477_MOESM1_ESM.pdf"><label>Additional file 1:</label><caption><p>For cytogenetics, quantitative PCR for copy number and gene expression analyses, methylation analysis, and ethics statement. Figure S1. Neuro-endocrine profile of the present case. Table S1. Methylation profile of the present case. Additional file References 1–3. (PDF 652 kb)</p></caption></media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>a-CGH</term>
<def>
<p id="Par4">Array-based Comparative Genome Hybridization</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p id="Par5">Brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>CNV</term>
<def>
<p id="Par6">Copy Number Variation</p>
</def>
</def-item>
<def-item>
<term>qPCR</term>
<def>
<p id="Par7">Quantitative Polymerase Chain Reaction</p>
</def>
</def-item>
<def-item>
<term>WAGR</term>
<def>
<p id="Par8">Wilms tumor, aniridia, genitourinary anomalies and mental retardation</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s12881-017-0477-5) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<p>We thank staffs at Baylor MGL for array-CGH analysis; Yoshiaki Kinoshita, Tomoaki Taguchi (Department of Pediatric Surgery, Kyushu University) for surgical treatments; Tatsuro Tajiri (Kyoto Prefectural University of Medicine) for diagnostic approaches.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par19">This study was supported by JSPS KAKENHI Grant Number 17K16268 (Y. Matsushita), 15 K0962 (Y.S.) and 17 K16301 (M.T.), a Health and Labour Sciences Research Grant on Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan (Y.S.), Life Science Foundation of Japan, Takeda Science Foundation, The Mother and Child Health Foundation, The Japan Epilepsy Research Foundation (Y.S.).</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>YS, TH and SO directed this study; YT, YM performed CNV analyses and SA supported experiments; KI and KO conducted and evaluated the neuro-endocrine profiles; YK managed chemotherapy; MK performed and supervised methylation analyses; MT, SA, YI, MS and HT assessed neuro-developmental findings; CAS mapped CNVs; YT, SO and YS wrote the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar2">
<title>Ethics approval and consent to participate</title>
<p id="Par20">This study was approved by the institutional review board at Kyushu University. The parents of the present case were informed to participate in this study with written consents.</p>
</sec>
<sec id="FPar3">
<title>Consent for publication</title>
<p id="Par21">Written informed consent was obtained from the parents for publication of the clinical details and any images in this report. A copy of the written consent is available for review by the Editor of this journal.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p id="Par22">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Publisher’s Note</title>
<p id="Par23">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantes</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bickmore</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ballesta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization</article-title>
<source/>Am J Hum Genet
          <year>1992</year>
<volume>51</volume>
<issue>6</issue>
<fpage>1286</fpage>
<lpage>1294</lpage>
<pub-id pub-id-type="pmid">1334370</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>QR</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levinn</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Menzie</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Jefferson-George</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Adler-Wailes</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Sanford</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Lacbawan</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>GR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor and obesity in the WAGR syndrome</article-title>
<source/>N Engl J Med
          <year>2008</year>
<volume>359</volume>
<issue>9</issue>
<fpage>918</fpage>
<lpage>927</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa0801119</pub-id>
<pub-id pub-id-type="pmid">18753648</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<mixed-citation publication-type="other">Diagnostic testing for Prader-Willi and Angleman syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee. Am J Hum Genet. 1996;58(5):1085–8.</mixed-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Menzie</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism</article-title>
<source/>Cytogenet Genome Res
          <year>2008</year>
<volume>122</volume>
<issue>2</issue>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1159/000172086</pub-id>
<pub-id pub-id-type="pmid">19096215</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egan</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Callicott</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Kolachana</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zaitsev</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function</article-title>
<source/>Cell
          <year>2003</year>
<volume>112</volume>
<issue>2</issue>
<fpage>257</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00035-7</pub-id>
<pub-id pub-id-type="pmid">12553913</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Siwko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>LGR4/GPR48 inactivation leads to aniridia-genitourinary anomalies-mental retardation syndrome defects</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<issue>13</issue>
<fpage>8767</fpage>
<lpage>8780</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.530816</pub-id>
<pub-id pub-id-type="pmid">24519938</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuke</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miyoshi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Muroya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Numakura</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular and clinical studies in 138 Japanese patients with silver-Russell syndrome</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>3</issue>
<fpage>e60105</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0060105</pub-id>
<pub-id pub-id-type="pmid">23533668</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Neurotrophin regulation of neural circuit development and function</article-title>
<source/>Nat Rev Neurosci
          <year>2013</year>
<volume>14</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3379</pub-id>
<pub-id pub-id-type="pmid">23254191</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Adlam</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yanovski</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>El Gharbawy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>YC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene</article-title>
<source/>Diabetes
          <year>2006</year>
<volume>55</volume>
<issue>12</issue>
<fpage>3366</fpage>
<lpage>3371</lpage>
<pub-id pub-id-type="doi">10.2337/db06-0550</pub-id>
<pub-id pub-id-type="pmid">17130481</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyons</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Mamounas</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ricaurte</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Bora</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Wihler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koliatsos</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Tessarollo</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1999</year>
<volume>96</volume>
<issue>26</issue>
<fpage>15239</fpage>
<lpage>15244</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.96.26.15239</pub-id>
<pub-id pub-id-type="pmid">10611369</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Goulding</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Zang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cepoi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cone</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Tecott</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor</article-title>
<source/>Nat Neurosci
          <year>2003</year>
<volume>6</volume>
<issue>7</issue>
<fpage>736</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="doi">10.1038/nn1073</pub-id>
<pub-id pub-id-type="pmid">12796784</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeo</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Connie Hung</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Rochford</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sivaramakrishnan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O'Rahilly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Farooqi</surname>
<given-names>IS</given-names>
</name>
</person-group>
<article-title>A de novo mutation affecting human TrkB associated with severe obesity and developmental delay</article-title>
<source/>Nat Neurosci
          <year>2004</year>
<volume>7</volume>
<issue>11</issue>
<fpage>1187</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="doi">10.1038/nn1336</pub-id>
<pub-id pub-id-type="pmid">15494731</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">Yamamoto T, Togawa M, Shimada S, Sangu N, Shimojima K, Okamoto N. Narrowing of the responsible region for severe developmental delay and autistic behaviors in WAGR syndrome down to 1.6 Mb including PAX6, WT1, and PRRG4. Am J Med Genet. 2014;164A(3):634–638.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>